Photodynamic therapy: Basic principles and potential uses for the veterinary ophthalmologist

Veterinary Ophthalmology

Volumn 10, Issue 6, 2007, Pages 337-343

  Giuliano, Elizabeth A ^a   Ota, Juri ^a   Tucker, Sheryl A ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Oncology equine; Photodynamic therapy; Squamous cell carcinoma

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; EYELID; OPHTHALMOLOGY; PHOTOCHEMOTHERAPY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; EYELIDS; OPHTHALMOLOGY; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EQUIDAE;

EID: 35449007646     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2007.00578.x     Document Type: Article

References (73)

1. Biel M. Advances in photodynamic therapy for the treatment of head and neck cancers. Lasers in Surgery and Medicine 2006 38 : 349 355.
2. Sharp DM, Lai S, Markey CM. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study. Clinical and Experimental Ophthalmology 2007 35 : 24 31.
3. Tang G, Hyman S, Schneider JH Jr. et al. Application of photodynamic therapy to the treatment of atherosclerotic plaques. Neurosurgery 1993 32 : 438 443 discussion 43.
4. Triesscheijn M, Baas P, Schellens JH et al. Photodynamic therapy in oncology. Oncologist 2006 11 : 1034 1044.
5. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. Porphyrins and Phthalocyanines 2001 5 : 105 129.
6. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. Journal of the National Cancer Institute 1998 90 : 889 905.
7. Evans HH, Horng MF, Ricanati M et al. Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines. Photochemistry and Photobiology 1997 66 : 690 696.
8. Marcus SL, McIntyre WR. Photodynamic therapy systems and applications. Expert Opinion on Emerging Drugs 2002 7 : 321 334.
9. Foote C. Mechanisms of photo-oxygenation. In : Phorphyrin Localization and Treatment of Tumors. (eds Doiron D, Alan R) Alan Liss, Inc., New York, 1984 3 18.
10. Emedia Science Ltd. Internet Photochemistry and Photobiology. http://www.photobiology.com. 2001.
11. Kessel D, Woodburn K. Biodistribution of photosensitizing agents. International Journal of Biochemistry and Cell Biology 1993 25 : 1377 1383.
12. Gaullier JM, Geze M, Santus R et al. Subcellular localization of and photosensitization by protoporphyrin IX human keratinocytes and fibroblasts cultivated with 5-aminolevulinic acid. Photochemistry and Photobiology 1995 62 : 114 122.
13. Woodburn KW, Vardaxis NJ, Hill JS et al. Subcellular localization of porphyrins using confocal laser scanning microscopy. Photochemistry and Photobiology 1991 54 : 725 732.
14. Geze M, Morliere P, Maziere JC et al. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. Journal of Photochemistry and Photobiology. B, Biology 1993 20 : 23 35.
15. Moan J, Sommer S. Uptake of the components of hematoporphyrin derivative by cells and tumours. Cancer Letters 1983 21 : 167 174.
16. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Research 1985 45 : 1608 1610.
17. Hilf R, Warne NW, Smail DB et al. Photodynamic inactivation of selected intracellular enzymes by hematoporphyrin derivative and their relationship to tumor cell viability in vitro. Cancer Letters 1984 24 : 165 172.
18. Miccoli L, Beurdeley-Thomas A, De Pinieux G et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Research 1998 58 : 5777 5786.
19. Agarwal ML, Clay ME, Harvey EJ et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Research 1991 51 : 5993 5996.
20. He J, Agarwal ML, Larkin HE et al. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochemistry and Photobiology 1996 64 : 845 852.
21. Kim HR, Luo Y, Li G et al. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Research 1999 59 : 3429 3432.
22. Perlin DS, Murant RS, Gibson SL et al. Effects of photosensitization by hematoporphyrin derivative on mitochondrial adenosine triphosphatase-mediated proton transport and membrane integrity of R3230AC mammary adenocarcinoma. Cancer Research 1985 45 : 653 658.
23. Fingar VH. Vascular effects of photodynamic therapy. Journal of Clinical Laser Medicine and Surgery 1996 14 : 323 328.
24. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochemistry and Photobiology 1992 55 : 145 157.
25. Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Survey of Ophthalmology 2000 45 : 195 214.
26. Henderson BW, Waldow SM, Mang TS et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Research 1985 45 : 572 576.
27. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Research 1987 47 : 3110 3114.
28. Chaudhuri K, Keck RW, Selman SH. Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy. Photochemistry and Photobiology 1987 46 : 823 827.
29. Gilissen MJ, van de Merbel-de Wit LE, Star WM et al. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Research 1993 53 : 2548 2552.
30. Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochemistry and Photobiology 1989 49 : 299 304.
31. Star WM, Marijnissen HP, van den Berg-Blok AE et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Research 1986 46 : 2532 2540.
32. Nelson JS, Liaw LH, Orenstein A et al. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. Journal of the National Cancer Institute 1988 80 : 1599 1605.
33. Chen Q, Chen H, Hetzel FW. Tumor oxygenation changes post-photodynamic therapy. Photochemistry and Photobiology 1996 63 : 128 131.
34. Korbelik M. Induction of tumor immunity by photodynamic therapy. Journal of Clinical Laser Medicine and Surgery 1996 14 : 329 334.
35. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. Journal of Photochemistry and Photobiology. B, Biology 1997 39 : 1 18.
36. Gollnick SO, Liu X, Owczarczak B et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Research 1997 57 : 3904 3909.
37. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. British Journal of Cancer 1995 71 : 549 555.
38. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Research 1999 59 : 1941 1946.
39. Korbelik M, Krosl G, Krosl J et al. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Research 1996 56 : 5647 5652.
40. Luksiene Z. Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Medicina (Kaunas) 2003 39 : 1137 1150.
41. Korbelik M, Krosl G, Chaplin DJ. Photofrin uptake by murine macrophages. Cancer Research 1991 51 : 2251 2255.
42. Korbelik M, Krosl G, Olive PL et al. Distribution of photofrin between tumour cells and tumour associated macrophages. British Journal of Cancer 1991 64 : 508 512.
43. Barrett AJ, Kennedy JC, Jones RA et al. The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volume tric titration study. Journal of Photochemistry and Photobiology. B, Biology 1990 6 : 309 323.
44. Freitas I. Lipid accumulation: the common feature to photosensitizer- retaining normal and malignant tissues. Journal of Photochemistry and Photobiology. B, Biology 1990 7 : 359 361.
45. Musser DA, Wagner JM, Datta-Gupta M. The interaction of tumor localizing porphyrins with collagen and elastin. Research Communications in Chemical Pathology and Pharmacology 1982 36 : 251 259.
46. Hamblin MR, Newman EL. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. Journal of Photochemistry and Photobiology. B, Biology 1994 26 : 147 157.
47. Mosley ST, Goldstein JL, Brown MS et al. Targeted killing of cultured cells by receptor-dependent photosensitization. Proceedings of the National Academy of Sciences of the United States of America 1981 78 : 5717 5721.
48. Jori G. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. Journal of Photochemistry and Photobiology. B, Biology 1996 36 : 87 93.
49. Allison BA, Pritchard PH, Levy JG. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. British Journal of Cancer 1994 69 : 833 839.
50. Grossweiner LI. Photodynamic therapy. Journal of Laser Applications 1995 7 : 51 57.
51. Hamblin MR, Newman EL. On the mechanism of the tumour-localising effect in photodynamic therapy. Journal of Photochemistry and Photobiology. B, Biology 1994 23 : 3 8.
52. Chen M, Pennathur A, Luketich JD. Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers in Surgery and Medicine 2006 38 : 396 402.
53. Pandey RK, Bellnier DA, Smith KM et al. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochemistry and Photobiology 1991 53 : 65 72.
54. Sternberg ED, Dolphin D. Second generation photodynamic agents: a review. Journal of Clinical Laser Medicine and Surgery 1993 11 : 233 241.
55. Aveline B, Hasan T, Redmond RW. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochemistry and Photobiology 1994 59 : 328 335.
56. Petermeier K, Tatar O, Inhoffen W et al. Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes. British Journal of Ophthalmology 2006 90 : 1034 1039.
57. Houle JM, Strong A. Clinical pharmacokinetics of verteporfin. Journal of Clinical Pharmacology 2002 42 : 547 557.
58. Richter AM, Cerruti-Sola S, Sternberg ED et al. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. Journal of Photochemistry and Photobiology. B, Biology 1990 5 : 231 244.
59. Lui H, Hobbs L, Tope WD et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology 2004 140 : 26 32.
60. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers in Medical Science 2002 17 : 173 186.
61. Keijzer M, Jacques SL, Prahl SA et al. Light distributions in artery tissue: Monte Carlo simulations for finite-diameter laser beams. Lasers in Surgery and Medicine 1989 9 : 148 154.
62. Pogue BW, Momma T, Wu HC et al. Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light. British Journal of Cancer 1999 80 : 344 351.
63. Bernstein EF, Thomas GF, Smith PD et al. Response of black and white guinea pig skin to photodynamic treatment using 514-nm light and dihematoporphyrin ether. Archives of Dermatology 1990 126 : 1303 1307.
64. Awan MA, Tarin SA. Review of photodynamic therapy. Surgeon 2006 4 : 231 236.
65. Blumenkranz MS, Bressler NM, Bressler SB et al. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of two randomized clinical trials - TAP report no. 5. Archives of Ophthalmology 2002 120 : 1307 1314.
66. Barbazetto IA, Lee TC, Rollins IS et al. Treatment of choroidal melanoma using photodynamic therapy. American Journal of Ophthalmology 2003 135 : 898 899.
67. Cappugi P, Campolmi P, Mavilia L et al. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. Journal of Chemotherapy 2001 13 : 494 502.
68. Fink-Puches R, Wolf P, Kerl H. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Archives of Dermatology 1997 133 : 1494 1495.
69. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. British Journal of Dermatology 2002 146 : 178 188.
70. Virgili G, Varano M, Giacomelli G et al. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia. American Journal of Ophthalmology 2007 143 : 77 82.
71. Giuliano E, McCaw D, MacDonald I et al. Photodynamic therapy for the treatment of periocular squamous cell carcinoma in horses. Investigative Ophthalmology and Visual Science 2004 45 : E 3566.
72. ® in horses. Applied Spectroscopy 2007 61 : 450 454.
73. Ota J, Giuliano EA, Mullen SF et al. Xenotransplantation of cryopreserved equine squamous cell carcinoma to athymic nude and SCID mice. Research in Veterinary Science 2007 doi: 10.1016/j.rvsc.2006.11.016.